Aurora Cannabis urges shareholders to reject hostile takeover offer by Curaleaf

Aurora Cannabis (ACB) is advising shareholders to reject Curaleaf's hostile takeover offer, calling it undervalued. Aurora highlights its debt-free status and C$149M cash, contrasting with Curaleaf's C$1B debt. Curaleaf's offer is US$4.00 per Aurora share, including shares and cash. Aurora shares closed at C$5.60 on the TSX.

Original reporting
Published Sep 2, 2026, 1:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 2, 2026, 2:31 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Aurora Cannabis urges shareholders to reject hostile takeover offer by Curaleaf — source image
Decision brief

The 30-second read

High
01

Why it matters

The hostile bid could reshape the competitive landscape in North America.

02

Market read

The announcement introduces a material M&A event that may move Aurora's stock and affect sector sentiment.

03

What to watch

Potential regulatory approvals and financing arrangements for Curaleaf are not detailed.

Relevance 8/10Novelty 8/10Timing: announcement day

Background

Aurora Cannabis is a Canadian cannabis producer; Curaleaf is a U.S. cannabis operator.

Market effects

Canadian cannabis sector may see heightened scrutiny of M&A valuations.

Toronto market could see a dip in cannabis stocks.

Limited; primarily affects North American cannabis investors.

Counterpoint

If Curaleaf secures financing, the bid could succeed despite shareholder opposition.

Key entities

  • Aurora Cannabis Inc.

    Target of the hostile takeover.

  • Curaleaf Holdings, Inc.

    Bidder proposing the acquisition.

Related articles

HighAI 9/10

Curaleaf Launches Campaign Backing Aurora Cannabis Takeover Bid

Curaleaf (TSE:CURA) launched a campaign urging Aurora Cannabis shareholders to accept its takeover offer, valuing Aurora at a 45% premium. The bid includes cash and Curaleaf shares, promising immediate value and synergies. Curaleaf highlights potential revenue of $1.5B and $350M in adjusted EBITDA, while criticizing Aurora's recent performance.

HighAI 9/10

Curaleaf Presses Aurora Shareholders to Support Takeover Bid

Curaleaf Holdings (TSE:CURA) urged Aurora Cannabis (ACB) shareholders to accept its takeover offer, valuing shares at a 45% premium. The deal includes cash and Curaleaf stock, aiming to create a global cannabis leader with $1.5B revenue and $350M adjusted EBITDA. Curaleaf cited Aurora's financial challenges and set a December 1, 2026 deadline for shareholder response.

$CURLFHighAI 9/10

Curaleaf Urges Aurora Shareholders To Back Bid, Seeks Halt To ATM Program

Curaleaf (CURLF) urged Aurora Cannabis (ACB.TO) shareholders to support its takeover offer, which provides 0.3463 Curaleaf shares and C$0.75 in cash per Aurora share. Curaleaf also asked the Alberta Securities Commission to halt Aurora's ATM share issuance program, citing potential dilution. Aurora opposes the bid. CURLF and ACB.TO shares are down 1.49% and 0.94%, respectively.